Inventor
GEGE CHRISTIAN
DE38 patents
⚠️ This page may combine multiple inventors who share the name “GEGE CHRISTIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
9 patentsUS9751874B2Sep 5, 2017
Hydroxy containing FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC35 citations94
US9938278B2Apr 10, 2018
FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC9 citations84
US9932332B2Apr 3, 2018
FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC7 citations84
US11739065B2Aug 29, 2023
FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC1 citations73
US11247986B2Feb 15, 2022
FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC1 citations73
US10774054B2Sep 15, 2020
FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC1 citations73
US10421730B2Sep 24, 2019
FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC3 citations73
US10329286B2Jun 25, 2019
FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC1 citations73
US12358903B2Jul 15, 2025
FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC0 citations62
INNOVATIVE MOLECULES GMBH
5 patentsUS11278534B2Mar 22, 2022
Enantiomers of substituted thiazoles as antiviral compounds
INNOVATIVE MOLECULES GMBH6 citations84
US10590094B2Mar 17, 2020
Aminothiazole derivatives useful as antiviral agents
INNOVATIVE MOLECULES GMBH6 citations71
US12527778B2Jan 20, 2026
Enantiomers of a series of antiviral compounds
INNOVATIVE MOLECULES GMBH0 citations61
US12295945B2May 13, 2025
Enantiomers of substituted thiazoles as antiviral compounds
INNOVATIVE MOLECULES GMBH0 citations61
US12552756B2Feb 17, 2026
Deuterated aminothiazole compounds as antiviral compounds
INNOVATIVE MOLECULES GMBH0 citations50
JANSSEN PHARMACEUTICA NV
5 patentsUS9850236B2Dec 26, 2017
Trifluoromethyl alcohols as modulators of RORγt
JANSSEN PHARMACEUTICA NV2 citations71
US10150762B2Dec 11, 2018
Trifluoromethyl alcohols as modulators of RORγt
JANSSEN PHARMACEUTICA NV0 citations52
US9861618B2Jan 9, 2018
Thiazoles as modulators of RORγt
JANSSEN PHARMACEUTICA NV0 citations52
US10080744B2Sep 25, 2018
Thiazoles as modulators of RORγt
JANSSEN PHARMACEUTICA NV0 citations51
US9845319B2Dec 19, 2017
Amide substituted thiazoles as modulators of RORyt
JANSSEN PHARMACEUTICA NV0 citations40
STERIX LTD
3 patentsUS7427610B2Sep 23, 2008
2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action
STERIX LTD8 citations72
USRE42132EFeb 8, 2011
Antitumoral D-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates
STERIX LTD0 citations51
US7244762B2Jul 17, 2007
Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamates
STERIX LTD1 citations51
ORSOBIO INC
3 patentsPHENEX PHARMACEUTICALS AG
3 patentsUS9815851B2Nov 14, 2017
Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
PHENEX PHARMACEUTICALS AG1 citations51
US9458104B2Oct 4, 2016
Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor RORγ
PHENEX PHARMACEUTICALS AG2 citations51
US10301272B2May 28, 2019
Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ]
PHENEX PHARMACEUTICALS AG0 citations41
ALANTOS PHARM HOLDING
2 patentsSCHERING AG
2 patentsSTEENECK CHRISTOPH
2 patentsUS8835441B2Sep 16, 2014
Heterobicyclic metalloprotease inhibitors
STEENECK CHRISTOPH3 citations55
US8946446B2Feb 3, 2015
Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-γ (ROR-γ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
STEENECK CHRISTOPH0 citations37